open access
Unusually high plasma values of many tumour markers in a patient with idiopathic pulmonary fibrosis
- Department of Radiotherapy, Chair of Oncology, Medical University of Lodz, Poland, Poland
- Department of Teleradiotherapy, Regional Cancer Centre, Copernicus Memorial Hospital of Lodz, Poland, Poland
- Department of Pneumology and Allergy, I Chair of Internal Medicine, Medical University of Lodz, Lodz, Poland
- Department of Fetal Medicine and Gynaecology, I Chair of Obstetrics and Gynaecology, Medical University of Lodz, Lodz, Poland
open access
Abstract
Abstract
Title
Unusually high plasma values of many tumour markers in a patient with idiopathic pulmonary fibrosis
Journal
Issue
Article type
Clinical vignette
Pages
101
Published online
2020-02-12
Page views
1500
Article views/downloads
861
DOI
Pubmed
Bibliographic record
Ginekol Pol 2020;91(2):101.
Authors
Leszek Gottwald
Mateusz Pajdzinski
Wojciech J. Piotrowski
Sebastian Majewski
Piotr Sieroszewski
Jacek Fijuth
- Martinez FJ, Collard HR, Pardo A, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017; 3: 17074.
- Raghu G, Remy-Jardin M, Myers JL, et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018; 198(5): 44–68.
- Fujita J, Obayashi Y, Yamadori I, et al. Marked elevation of CA19-9 in a patient with idiopathic pulmonary fibrosis: CA19-9 as a bad prognostic factor. Respirology. 1998; 3(3): 211–214.
- Maher TM, Oballa E, Simpson JK, et al. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. Lancet Respir Med. 2017; 5(12): 946–955.
- Rusanov V, Kramer MR, Raviv Y, et al. The significance of elevated tumor markers among patients with idiopathic pulmonary fibrosis before and after lung transplantation. Chest. 2012; 141(4): 1047–1054.